SEC Comment Letter 0000000000-24-008126 to Tharimmune, Inc. (THAR) (CIK 0001861657) (THAR)
Tharimmune, Inc. (THAR) (CIK 0001861657)
Date: July 17, 2024 · CIK: 0001861657 · Accession: 0000000000-24-008126
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280814
Letter
July 17, 2024 Randy Milby Chief Executive Officer Tharimmune, Inc. 1200 Route 22 East, Suite 2000 Bridgewater, NJ 08807 Re:Tharimmune, Inc. Registration Statement on Form S-3 Filed July 15, 2024 File No. 333-280814 Dear Randy Milby: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Emily A. Mastoloni, Esq.
Show Raw Text
July 17, 2024
Randy Milby
Chief Executive Officer
Tharimmune, Inc.
1200 Route 22 East, Suite 2000
Bridgewater, NJ 08807
Re:Tharimmune, Inc.
Registration Statement on Form S-3
Filed July 15, 2024
File No. 333-280814
Dear Randy Milby:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Emily A. Mastoloni, Esq.